The last 10 global press releases

To find more press releases: 

2022
2021
2020
2019
2018
2017
2016
November 17, 2022
Press releases
Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
November 11, 2022
Press releases
Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis
November 10, 2022
Press releases
Press Release: Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
November 4, 2022
Press releases
Press Release: European Commission grants first approval worldwide of Beyfortus® (nirsevimab) for prevention of RSV disease in infants
October 28, 2022
Press releases
Press Release: Continued strong growth in Q3 with key regulatory milestones achieved
October 26, 2022
Press releases
Media Update: New two-year efficacy and safety data for tolebrutinib, Sanofi’s investigational, brain-penetrant and bioactive BTK inhibitor, to be presented at ECTRIMS 2022
October 11, 2022
Press releases
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old
September 29, 2022
Press releases
Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
September 28, 2022
Press releases
Press Release: Availability of the Q3 2022 Memorandum for modelling purposes
September 16, 2022
Press releases
Media Update: CHMP recommends approval of Enjaymo™ (sutimlimab), first and only approved treatment for hemolytic anemia in adult patients with cold agglutinin disease

The last 5 COVID-19 press releases

Local press releases

September 3, 2020 - US
Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMO

September 9, 2020 - US
Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020